Latest News about AXSM
Recent news which mentions AXSM
3 Red-Hot Stocks That Could Continue to Beat the Market
October 13, 2022
From Motley Fool
Got $1,000? These 3 Stocks Could Double Your Money in 5 Years.
October 12, 2022
From Motley Fool
From Motley Fool
These 7 Biotech Stocks Are Set to Boom in 2023
October 10, 2022
From InvestorPlace
Better Buy: Moderna vs. Axsome Therapeutics
October 10, 2022
From Motley Fool
If You Invested $5,000 in Axsome Therapeutics in 2019, This Is How Much You Would Have Today
October 08, 2022
Tickers
AXSM
From Motley Fool
Jim Cramer On This Industrial Stock: 'You Don't Know What's In It'
October 07, 2022
From Benzinga
3 Stocks Savvy Investors Are Buying Hand Over Fist
October 06, 2022
From Motley Fool
3 Healthcare Stocks That Could Make You Richer
October 05, 2022
From Motley Fool
Axsome Therapeutics' Sunosi Improves Cognitive Function In Patients With Sleep Disorder
October 03, 2022
Tickers
AXSM
From Benzinga
10 Health Care Stocks Whale Activity In Today's Session
September 29, 2022
From Benzinga
2 No-Brainer Biotech Stocks to Buy Right Now
September 26, 2022
From Motley Fool
3 Monster Stocks in the Making
September 24, 2022
From Motley Fool
If You Invested $10,000 in Axsome Therapeutics 5 Years Ago, This Is How Much You Would Have Today
September 23, 2022
From Motley Fool
2 Reasons to Buy Axsome Therapeutics, and 1 Reason to Sell
September 22, 2022
From Motley Fool
2 Biotech Stocks That Could Make You Richer
September 17, 2022
From Motley Fool
Is It Too Late to Buy Axsome Therapeutics Stock?
September 17, 2022
From Motley Fool
7 Top-Rated Biotech Stocks to Buy for Q4
September 15, 2022
From InvestorPlace
3 Top Healthcare Stocks Defying the Bear Market
September 15, 2022
From Motley Fool
Biotech Stocks Stand to Benefit as Biden Announces Support for Industry
September 12, 2022
From InvestorPlace
3 Growth Stocks That Are Crushing It This Year
September 10, 2022
From Motley Fool
2 Top Biotech Stocks Defying the Bear Market
September 10, 2022
From Motley Fool
Is Axsome Therapeutics a Buy?
September 09, 2022
From Motley Fool
Important Biotech Catalysts For September 8, 2022 - End Of The Day Summary
September 08, 2022
From Benzinga
Mizuho Bolsters Price Target By 55% On This Migraine Stock
September 07, 2022
Tickers
AXSM
From Benzinga
Nasdaq Bear Market: 2 Top Growth Stocks You'll Wish You'd Bought on the Dip
September 05, 2022
From Motley Fool
Recap Of Thursday's Biotech Catalysts - End Of the Day Summary
September 01, 2022
From Benzinga
Axsome Therapeutics Commences Late-Stage Migraine Study
September 01, 2022
Tickers
AXSM
From Benzinga
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.